自身抗体状态对系统性硬化症器官受累与死亡风险分层的影响:法国1605例多中心队列研究经验
在法国七家大学医院1605例系统性硬化症(SSc)患者中回顾性分析九种自身抗体与器官受累及死亡的关系。多因素分析显示抗拓扑异构酶I与间质性肺病和死亡相关,抗RNA聚合酶III与硬皮病肾危象和死亡相关,而皮肤表型与生存或器官受累无关。提示仅凭皮肤扩展程度分类不足以定义预后和表型。
要点
- 抗拓扑异构酶I与间质性肺病(OR=3.27)和死亡(HR=1.9)独立相关。
- 抗RNA聚合酶III与硬皮病肾危象(OR=7.05)和死亡(HR=2.35)独立相关。
- 皮肤表型在多因素分析中与生存或器官受累无关。
核心结论
- 与皮肤表型不同,自身抗体特异性与SSc器官受累和结局存在强关联,仅基于皮肤扩展的分类不足以定义预后和表型。
研究设计与样本
- 回顾性分析法国七家大学医院随访的1605例SSc患者(其中367例为弥漫性皮肤型SSc),评估皮肤表型、九种自身抗体、器官受累和死亡,并行多因素分析。
主要发现
- 多因素分析中,抗拓扑异构酶I与间质性肺病(OR=3.27,95%CI 2.42至4.42)和死亡(HR=1.9,95%CI 1.01至3.58)相关。
- 抗RNA聚合酶III与硬皮病肾危象(OR=7.05,95%CI 2.98至16.72)和死亡(HR=2.35,95%CI 1.12至4.93)相关。
- 抗U1RNP与关节炎相关(OR=3.79,95%CI 2.16至6.67)。
- 抗Pm/Scl与肌炎相关(OR=7.09,95%CI 3.87至12.98),抗Ku与肌炎相关(OR=7.99,95%CI 2.41至26.46)。
- 未行逐步选择的多因素分析中,皮肤表型与生存或器官受累无关。
关键数值与推荐
- 抗拓扑异构酶I:间质性肺病OR=3.27(95%CI 2.42至4.42),死亡HR=1.9(95%CI 1.01至3.58)。
- 抗RNA聚合酶III:硬皮病肾危象OR=7.05(95%CI 2.98至16.72),死亡HR=2.35(95%CI 1.12至4.93)。
- 抗U1RNP:关节炎OR=3.79(95%CI 2.16至6.67)。
- 抗Pm/Scl:肌炎OR=7.09(95%CI 3.87至12.98);抗Ku:肌炎OR=7.99(95%CI 2.41至26.46)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Systemic sclerosis (SSc) is a rare autoimmune disease currently classified into two subgroups based on skin extension. The aim of this study was to determine in a large cohort whether the determination of autoantibody (AAb) profile among a full antinuclear AAbs panel including nine specificities had a higher impact than skin phenotype on stratifying the risk of organ involvement and mortality in SSc. METHODS: Data for patients with SSc followed in seven French university hospitals were retrospectively analysed in terms of skin phenotype, AAbs (anti-topoisomerase I (ATA), anticentromere (ACA), anti-RNA polymerase III (anti-RNAPIII), anti-U1RNP, anti-U3RNP, anti-Pm/Scl, anti-Ku, anti-Th/To, anti-NOR90), organ involvement and mortality. Multivariate analyses were performed to identify independent factors associated with organ involvement and mortality. RESULTS: We included 1605 patients with SSc (367 with diffuse cutaneous SSc). On multivariate analysis, ATAs were associated with interstitial lung disease and mortality (OR=3.27 (95% CI 2.42 to 4.42); HR=1.9 (95% CI 1.01 to 3.58)), anti-RNAPIII with scleroderma renal crisis and mortality (OR=7.05 (95% CI 2.98 to 16.72); HR=2.35 (95% CI 1.12 to 4.93)), anti-U1RNP with arthritis (OR=3.79 (95% CI 2.16 to 6.67)), anti-Pm/Scl and anti-Ku with myositis (OR=7.09 (95% CI 3.87 to 12.98) and 7.99 (95% CI 2.41 to 26.46)). The skin phenotype was not associated with survival or organ involvement on multivariate analysis without stepwise selection. CONCLUSION: This study unravels, by contrast with skin phenotype, a strong association between AAbs specificities, organ involvement and outcome in SSc and suggests that patients' classification based on only skin extension is not sufficient for defining prognosis and phenotype.
引用
- Didier K, Sobanski V, Robbins A, et al. Impact of autoantibody status on stratifying the risk of organ involvement and mortality in SSc: experience from a multicentre French cohort of 1605 patients. RMD Open. 2024. PMID: 39572073. doi:10.1136/rmdopen-2024-004580
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。